Pharmaniaga Bhd | Income Statement

Fiscal year is January-December. All values MYR Millions.
2013
2014
2015
2016
2017
Sales/Revenue
1,947
2,123
2,189
2,189
2,324
Cost of Goods Sold (COGS) incl. D&A
1,659
1,785
1,851
1,862
2,005
Gross Income
288
338
339
327
319
SG&A Expense
182
197
212
224
224
EBIT
106
140
126
104
95
Unusual Expense
-
-
-
-
5
Non Operating Income/Expense
-
6
1
1
6
Interest Expense
15
17
15
34
29
Pretax Income
93
126
113
72
73
Income Tax
36
31
28
26
18
Consolidated Net Income
57
94
85
46
55
Net Income
55
94
84
46
54
Net Income After Extraordinaries
55
94
84
46
54
Net Income Available to Common
55
94
84
46
54
EPS (Basic)
0.21
0.36
0.32
0.18
0.21
Basic Shares Outstanding
259
259
259
259
260
EPS (Diluted)
0.21
0.36
0.32
0.18
0.21
Diluted Shares Outstanding
259
259
259
260
260
EBITDA
170
190
183
149
141
Other Operating Expense
-
-
-
-
-
Non-Operating Interest Income
1
1
1
1
1
Minority Interest Expense
-
-
2
1
1

About Pharmaniaga Bhd

View Profile
Address
No. 7, Lorong Keluli 1B
Shah Alam Selangor 40000
Malaysia
Employees -
Website http://www.pharmaniaga.com
Updated 09/14/2018
Pharmaniaga Bhd. is an investment holding company, which engages in the provision of healthcare products and services. It operates through the following segments: Logistics and Distribution, Manufacturing, and Indonesia.